SunWay Biotech Balance Sheet Health
Financial Health criteria checks 6/6
SunWay Biotech has a total shareholder equity of NT$492.9M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$835.8M and NT$342.9M respectively. SunWay Biotech's EBIT is NT$116.7M making its interest coverage ratio 27.5. It has cash and short-term investments of NT$282.2M.
Key information
0%
Debt to equity ratio
NT$0
Debt
Interest coverage ratio | 27.5x |
Cash | NT$282.22m |
Equity | NT$492.93m |
Total liabilities | NT$342.88m |
Total assets | NT$835.81m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 1271's short term assets (NT$424.3M) exceed its short term liabilities (NT$83.5M).
Long Term Liabilities: 1271's short term assets (NT$424.3M) exceed its long term liabilities (NT$259.3M).
Debt to Equity History and Analysis
Debt Level: 1271 is debt free.
Reducing Debt: 1271 has no debt compared to 5 years ago when its debt to equity ratio was 10.6%.
Debt Coverage: 1271 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 1271 has no debt, therefore coverage of interest payments is not a concern.